Cite
Dochez V, Randet M, Renaudeau C, et al. Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial. J Clin Med. 2019;8(11)doi: 10.3390/jcm8111784.
Dochez, V., Randet, M., Renaudeau, C., Dimet, J., Le Thuaut, A., Winer, N., Thubert, T., Vaucel, E., Caillon, H., & Ducarme, G. (2019). Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial. Journal of clinical medicine, 8(11), . https://doi.org/10.3390/jcm8111784
Dochez, Vincent, et al. "Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial." Journal of clinical medicine vol. 8,11 (2019). doi: https://doi.org/10.3390/jcm8111784
Dochez V, Randet M, Renaudeau C, Dimet J, Le Thuaut A, Winer N, Thubert T, Vaucel E, Caillon H, Ducarme G. Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial. J Clin Med. 2019 Oct 25;8(11). doi: 10.3390/jcm8111784. PMID: 31699959; PMCID: PMC6912210.
Copy
Download .nbib